Eikon Therapeutics, Inc. Common Stock (EIKN) Financials

EIKN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 779.6 million 313.1 million
March 31, 2026 850.8 million 300.2 million
Dec. 31, 2025 594.7 million 1.5 billion
Sept. 30, 2025 642.3 million 1.4 billion

EIKN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -65.2 million ?
March 31, 2026 -90.1 million 2.8 million
Dec. 31, 2025 -41.8 million 3.9 million
Sept. 30, 2025 ? ?

EIKN Net Income

No data available :(

EIKN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 531.6 million - 242.8 million
March 31, 2026 512.6 million - 245.1 million
Dec. 31, 2025 336.0 million - 257.3 million
Sept. 30, 2025 375.9 million - 240.7 million

EIKN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 54.1 million
March 31, 2026 54.1 million
Dec. 31, 2025 54.1 million
Sept. 30, 2025 54.0 million

EIKN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 251000 75.5 million 12.9 million -
March 31, 2026 262000 70.0 million 12.2 million -
Dec. 31, 2025 66000 65.2 million 17.9 million -
Sept. 30, 2025 - - - -

EIKN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 5.0 million
March 31, 2026 - 5.1 million
Dec. 31, 2025 - 5.1 million
Sept. 30, 2025 - -

EIKN

Price: $10.75

52 week price:
7.90
17.40

Earnings Per Share: -5.95 USD

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 598.5 million

Links: